NO20082354L - Nye sykliske forbindelser - Google Patents
Nye sykliske forbindelserInfo
- Publication number
- NO20082354L NO20082354L NO20082354A NO20082354A NO20082354L NO 20082354 L NO20082354 L NO 20082354L NO 20082354 A NO20082354 A NO 20082354A NO 20082354 A NO20082354 A NO 20082354A NO 20082354 L NO20082354 L NO 20082354L
- Authority
- NO
- Norway
- Prior art keywords
- hepatitis
- cyclic compounds
- new cyclic
- virus
- replication
- Prior art date
Links
- 150000001923 cyclic compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 108010069514 Cyclic Peptides Proteins 0.000 abstract 1
- 102000001189 Cyclic Peptides Human genes 0.000 abstract 1
- 241000711549 Hepacivirus C Species 0.000 abstract 1
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000006462 rearrangement reaction Methods 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73001105P | 2005-10-26 | 2005-10-26 | |
| US75120405P | 2005-12-19 | 2005-12-19 | |
| PCT/JP2006/321924 WO2007049803A1 (en) | 2005-10-26 | 2006-10-26 | New cyclic peptide compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082354L true NO20082354L (no) | 2008-07-01 |
Family
ID=37847219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082354A NO20082354L (no) | 2005-10-26 | 2008-05-23 | Nye sykliske forbindelser |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7872097B2 (ru) |
| EP (1) | EP1957518B1 (ru) |
| JP (1) | JP5218051B2 (ru) |
| KR (1) | KR101273681B1 (ru) |
| CN (1) | CN101305019B (ru) |
| AU (1) | AU2006306974B2 (ru) |
| BR (1) | BRPI0617781A2 (ru) |
| CA (1) | CA2623898C (ru) |
| ES (1) | ES2557477T3 (ru) |
| IL (1) | IL190286A0 (ru) |
| NO (1) | NO20082354L (ru) |
| PL (1) | PL1957518T3 (ru) |
| PT (1) | PT1957518E (ru) |
| RU (1) | RU2423377C2 (ru) |
| TW (1) | TWI391403B (ru) |
| WO (1) | WO2007049803A1 (ru) |
| ZA (1) | ZA200803525B (ru) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2396170T3 (es) | 2007-05-02 | 2013-02-19 | Astellas Pharma Inc. | Nuevos compuestos péptídicos ciclicos |
| JP5625910B2 (ja) * | 2008-09-24 | 2014-11-19 | アステラス製薬株式会社 | ペプチド化合物およびその製造方法 |
| NZ594755A (en) * | 2009-01-30 | 2013-12-20 | Enanta Pharm Inc | Cyclosporin analogues for preventing or treating hepatitis c infection |
| US8481483B2 (en) | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| CA2761469A1 (en) * | 2009-05-15 | 2010-11-18 | Stichting Het Nederlands Kanker Instituut | Lysine compounds and their use in site- and chemoselective modification of peptides and proteins |
| US8367053B2 (en) | 2009-07-09 | 2013-02-05 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| US8349312B2 (en) | 2009-07-09 | 2013-01-08 | Enanta Pharmaceuticals, Inc. | Proline substituted cyclosporin analogues |
| US8685917B2 (en) | 2009-07-09 | 2014-04-01 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| JP2013516424A (ja) * | 2009-12-30 | 2013-05-13 | サイネクシス，インコーポレーテッド | シクロスポリン類似体 |
| US20150218103A1 (en) | 2012-08-25 | 2015-08-06 | The Johns Hopkins University | Gapdh cascade inhibitor compounds and methods of use and treatment of stress induced disorders including mental illness |
| JP2015532277A (ja) | 2012-09-29 | 2015-11-09 | ノバルティス アーゲー | 環状ペプチドおよび医薬としてのその使用 |
| US8906853B2 (en) | 2012-11-28 | 2014-12-09 | Enanta Pharmaceuticals, Inc. | [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection |
| SG11201601274QA (en) * | 2013-08-26 | 2016-03-30 | Enanta Pharm Inc | Cyclosporin analogues for preventing or treating hepatitis c |
| US9669095B2 (en) | 2014-11-03 | 2017-06-06 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues for preventing or treating hepatitis C infection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05271267A (ja) * | 1991-04-23 | 1993-10-19 | Fujisawa Pharmaceut Co Ltd | Ｆｒ９０１４５９物質、その製法及び用途 |
| ES2255275T3 (es) | 1998-07-01 | 2006-06-16 | Debiopharm S.A. | Nueva ciclosporina con perfil de actividad mejorado. |
| EP1372695A2 (en) * | 2000-10-19 | 2004-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Cell damage inhibitor |
| GB0320638D0 (en) * | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| JP2007015926A (ja) * | 2003-10-06 | 2007-01-25 | Fujisawa Pharmaceut Co Ltd | Ｃ型肝炎治療剤 |
| NZ554412A (en) | 2004-10-01 | 2011-01-28 | Debiopharm Sa | Use of [D-MeAla]3-[EtVal]4-cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said [D-MeAla]3-[EtVal]4-cyclosporin |
| KR101309409B1 (ko) | 2004-10-01 | 2013-09-23 | 싸이넥시스, 인크. | Ｃ형 간염 바이러스 감염의 치료 및 예방을 위한 ３-에테르및 ３-티오에테르 치환된 시클로스포린 유도체 |
| JP4735861B2 (ja) | 2004-11-22 | 2011-07-27 | アステラス製薬株式会社 | 新規環状ペプチド化合物 |
-
2006
- 2006-10-26 US US12/083,551 patent/US7872097B2/en active Active
- 2006-10-26 AU AU2006306974A patent/AU2006306974B2/en not_active Ceased
- 2006-10-26 BR BRPI0617781-6A patent/BRPI0617781A2/pt not_active Application Discontinuation
- 2006-10-26 ES ES06822844.4T patent/ES2557477T3/es active Active
- 2006-10-26 EP EP06822844.4A patent/EP1957518B1/en active Active
- 2006-10-26 PT PT68228444T patent/PT1957518E/pt unknown
- 2006-10-26 TW TW095139941A patent/TWI391403B/zh not_active IP Right Cessation
- 2006-10-26 KR KR1020087012431A patent/KR101273681B1/ko active IP Right Grant
- 2006-10-26 RU RU2008116674/04A patent/RU2423377C2/ru not_active IP Right Cessation
- 2006-10-26 PL PL06822844T patent/PL1957518T3/pl unknown
- 2006-10-26 WO PCT/JP2006/321924 patent/WO2007049803A1/en active Application Filing
- 2006-10-26 CA CA2623898A patent/CA2623898C/en not_active Expired - Fee Related
- 2006-10-26 JP JP2008521463A patent/JP5218051B2/ja not_active Expired - Fee Related
- 2006-10-26 CN CN2006800390294A patent/CN101305019B/zh not_active Expired - Fee Related
-
2008
- 2008-03-19 IL IL190286A patent/IL190286A0/en unknown
- 2008-04-22 ZA ZA2008/03525A patent/ZA200803525B/en unknown
- 2008-05-23 NO NO20082354A patent/NO20082354L/no not_active Application Discontinuation
-
2010
- 2010-07-21 US US12/840,488 patent/US8252895B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080065297A (ko) | 2008-07-11 |
| ES2557477T3 (es) | 2016-01-26 |
| PL1957518T3 (pl) | 2016-07-29 |
| CN101305019A (zh) | 2008-11-12 |
| JP5218051B2 (ja) | 2013-06-26 |
| RU2423377C2 (ru) | 2011-07-10 |
| US20100286033A1 (en) | 2010-11-11 |
| IL190286A0 (en) | 2011-08-01 |
| AU2006306974B2 (en) | 2011-09-22 |
| CA2623898A1 (en) | 2007-05-03 |
| AU2006306974A1 (en) | 2007-05-03 |
| JP2009513562A (ja) | 2009-04-02 |
| BRPI0617781A2 (pt) | 2011-08-09 |
| US7872097B2 (en) | 2011-01-18 |
| EP1957518A1 (en) | 2008-08-20 |
| TW200732351A (en) | 2007-09-01 |
| KR101273681B1 (ko) | 2013-06-25 |
| ZA200803525B (en) | 2009-08-26 |
| PT1957518E (pt) | 2016-02-26 |
| CN101305019B (zh) | 2012-12-12 |
| CA2623898C (en) | 2013-12-24 |
| RU2008116674A (ru) | 2009-10-27 |
| TWI391403B (zh) | 2013-04-01 |
| US8252895B2 (en) | 2012-08-28 |
| US20090170755A1 (en) | 2009-07-02 |
| WO2007049803A1 (en) | 2007-05-03 |
| EP1957518B1 (en) | 2015-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082354L (no) | Nye sykliske forbindelser | |
| MX2009011512A (es) | Nuevos compuestos peptidos ciclicos. | |
| ATE365213T1 (de) | Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern | |
| CY1112115T1 (el) | Παραγωγα φαινοξυοξικου οξεος χρησιμα για τη θεραπευτικη αντιμετωπιση ασθενειων του αναπνευστικου | |
| BRPI0415288A (pt) | composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto | |
| BRPI0409227A (pt) | composto, composição farmacêutica, uso de um composto, intermediário, e, processo para a preparação de um composto | |
| CY1110318T1 (el) | Παραγωγα φαινοξυοξικου οξεος | |
| BRPI0718586A2 (pt) | Composto, processo para a sua preparação, composição farmacêutica contendo o mesmo, usos deste e método de tratamento ou prevenção de doenças | |
| NO20080745L (no) | Nye peptider for anvendelse i behandling av fedme | |
| BRPI0513819A (pt) | inibidores de hsp90 | |
| ATE405564T1 (de) | 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten | |
| CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
| BRPI0514133A (pt) | compostos de fórmula i, processo para a sua fabricação, composições farmacêuticas, método para o tratamento e/ou profilaxia de doença que são mediadas por inibidores de cetp e uso dos compostos de fórmula i | |
| NO330888B1 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom | |
| NO20072290L (no) | Organiske forbindelser. | |
| WO2005002526A3 (en) | Method and compositions for treatment of viral infections | |
| DE502004008819D1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| DE112004000961D2 (de) | Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen | |
| NO20070665L (no) | Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer | |
| NO20081681L (no) | N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| TW200510352A (en) | Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals | |
| BRPI0415781A (pt) | método para o tratamento de diabetes em um paciente e kit farmacêutico | |
| BRPI0512951A (pt) | compostos, processo para sua fabricação, composições farmacêuticas contendo os mesmos, uso e método para tratamento e/ou prevenção de doenças que são moduladas pelos agonistas de ppar(delta) e/ou ppar(alpha) | |
| BRPI0911159A2 (pt) | compostos derivados de ácido 4-dimetilaminobutírico, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento terapêutico ou profilático de enfermidades que são moduladas por inibidres de cpt2 e uso destes compostos | |
| ATE508749T1 (de) | Antidepressiva zur prophylaxe und therapie von zystischer fibrose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |